A detailed history of Advisory Resource Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Advisory Resource Group holds 1,528 shares of MRK stock, worth $195,156. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,528
Holding current value
$195,156
% of portfolio
0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 17, 2024

BUY
$113.24 - $131.95 $173,030 - $201,619
1,528 New
1,528 $201,000
Q3 2023

Dec 05, 2023

SELL
$102.95 - $114.33 $2.43 Million - $2.7 Million
-23,600 Reduced 89.36%
2,809 $289,000
Q2 2023

Jul 11, 2023

SELL
$108.61 - $118.38 $30,302 - $33,028
-279 Reduced 1.05%
26,409 $3.05 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $140,410 - $156,669
1,364 Added 5.39%
26,688 $2.84 Million
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $238,011 - $305,163
-2,722 Reduced 9.71%
25,324 $0
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $11,749 - $13,199
139 Added 0.5%
28,046 $2.42 Million
Q2 2022

Jul 21, 2022

SELL
$83.49 - $94.64 $367,940 - $417,078
-4,407 Reduced 13.64%
27,907 $2.54 Million
Q1 2022

Apr 06, 2022

BUY
$73.51 - $82.4 $115,263 - $129,203
1,568 Added 5.1%
32,314 $2.65 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $3,975 - $4,979
-55 Reduced 0.18%
30,746 $2.51 Million
Q3 2021

Oct 26, 2021

BUY
$71.68 - $78.83 $19,496 - $21,441
272 Added 0.89%
30,801 $2.31 Million
Q2 2021

Aug 19, 2021

BUY
$70.31 - $77.77 $446,609 - $493,995
6,352 Added 26.27%
30,529 $2.37 Million
Q1 2021

May 24, 2021

BUY
$68.86 - $81.11 $1.66 Million - $1.96 Million
24,177 New
24,177 $1.86 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Advisory Resource Group Portfolio

Follow Advisory Resource Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.